Plexium
PrivateLast Round
VC Round
Aug 25, 2025
Total Funding Raised
$165.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Plexium is a biotechnology company that develops targeted protein degradation therapeutics for the treatment of cancer and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Plexium Comparables
Compare Plexium with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proxygen | 93% | |
| Amphista Therapeutics | 90% | |
| Ambagon Therapeutics | 90% |
Plexium Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 25, 2025 | ||||
| VC Round | Aug 25, 2024 | ||||
| Series B | Feb 23, 2022 | ||||
| Series A Extension | Jan 21, 2021 | ||||
| Series A | Oct 17, 2019 | ||||
Seed | Feb 1, 2018 |
Key People
Founding team and executive leadership
Plexium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Series A, Series A Extension |
| Surveyor Capital | Series B |
| SoftBank Investment Advisers | Series B |
| RA Capital Management | Series B |
| TCG Crossover | Series B |
| A. M. Pappas & Associates | Series B |
| DCVC Bio | Series A Extension, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 73% MoM.
- Apr 28, 2025
Developing selective monovalent degrader programs targeting SMARCA2, IKZF2, and CDK2.
Plexium Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Plexium's valuation, stock price, and market status.
Is Plexium a public or private company?
Plexium is a private company.
What is the current stock price of Plexium?
Plexium is a private company with no public stock price. No recent secondary market data is available.
How much is Plexium worth (valuation)?
Valuation information for Plexium is not publicly available.
Can I buy Plexium stock?
Plexium shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Plexium's last funding round?
Plexium's most recent funding round was VC Round on August 25, 2024.
Who are the main investors in Plexium?
Key investors in Plexium include The Column Group, TCG Crossover, DCVC Bio, Lux Capital, The Chernin Group.
Will Plexium IPO soon?
No public IPO plans have been announced for Plexium.
How can I track Plexium secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Plexium's secondary market activity and sign up for updates.